STAT3, but not ERKs, mediates the IL-6–induced proliferation of renal cancer cells, ACHN and 769P
- 1 March 2002
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 61 (3), 926-938
- https://doi.org/10.1046/j.1523-1755.2002.00206.x
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- The role of STATs in transcriptional control and their impact on cellular functionOncogene, 2000
- An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STATOncogene, 1997
- Two Signals Are Necessary for Cell Proliferation Induced by a Cytokine Receptor gp130: Involvement of STAT3 in Anti-ApoptosisImmunity, 1996
- Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitorNature, 1996
- Requirement for MAP Kinase (ERK2) Activity in Interferon α- and Interferon β-Stimulated Gene Expression Through STAT ProteinsScience, 1995
- Enhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src OncoproteinScience, 1995
- TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT PathwayAnnual Review of Biochemistry, 1995
- Molecular cloning and expression of an IL-6 signal transducer, gp130Cell, 1990
- Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130Cell, 1989
- Interleukin‐6 (IL‐6) functions as an in vitro autocrine growth factor in renal cell carcinomasFEBS Letters, 1989